Video Experimental Relacionado
Updated: Jan 8, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Esclerosis Sistémica Asociada a Enfermedad Pulmonar Intersticial: Lo que Sabemos y Cómo Incorporar las Guías en la
Anthony J Esposito1, Kavitha C Selvan1, Carrie Richardson2
1Division of Pulmonary and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
El manejo de la esclerosis sistémica-enfermedad pulmonar intersticial (SSc-ILD) es complejo. Esta revisión sintetiza las guías para la detección y el tratamiento, enfatizando el micofenolato como la terapia fuertemente recomendada para SSc-ILD.
Más Videos Relacionados
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Videos de Conceptos Relacionados
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Standards of Care II
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment